SUMMIT THERAPEUTICS

• 72110 - Research and experimental development on biotechnology

We value everyone's role and contribution. We believe everyone has good intentions and acts with integrity. We create and open and inclusive environment... We promote debate, take advice and listen carefully. We are open to changing our minds and when necessary disagree. We find solutions and deliver our goals... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT'). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK, Cambridge, UK, and Menlo Park, California

Also known as: Summit Therapeutics Inc., SUMMIT THERAPEUTICS LIMITED

Previous names: COBRADRAGON PUBLIC LIMITED COMPANY, SUMMIT CORPORATION PLC, VASTOX PLC

Registration numbers: 05197494 (CH), ZA066410 (W)

Primary location: Cambridge United Kingdom